<DOC>
	<DOCNO>NCT00346918</DOCNO>
	<brief_summary>The aim study investigate whether Rapamune use low dose ( 2 mg/d ) retard cyst growth slow renal functional deterioration patient ADPKD .</brief_summary>
	<brief_title>Sirolimus ( RapamuneÂ® ) Autosomal Dominant Polycystic Kidney Disease ( ADPKD )</brief_title>
	<detailed_description>Currently treatment ADPKD supportive care blood pressure control . Usually dialytic treatment renal transplantation become necessary disease progress end-stage renal failure.We others could demonstrate rapamycin , classical mTOR inhibitor , retard cyst growth preserve renal function rodent model ADPKD . The aim study investigate whether Rapamune ( 2 mg/d ) retard cyst growth slow renal functional deterioration patient ADPKD . We anticipate slow disease progression delay need chronic renal replacement therapy inhibition mTOR Rapamune . This 24-month prospective , control , open label study 2 parallel group patient ADPKD . Patients randomize 1:1 ratio one 2 treatment arm . Primary endpoint percentage change renal volume measure high resolution magnetic resolution imaging .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Male female ADPKD patient 18 40 year age measure GFR high 70 ml/min 1.73m2 documented kidney volume progression inform consent Female childbearing potential planning become pregnant , pregnant and/or lactating , unwilling use effective mean contraception increase liver enzymes ( 2fold normal value ) hypercholesterolemia ( fast cholesterol &gt; 8 mmol/l ) hypertriglyceridaemia ( &gt; 5 mmol/l ) control lipid lowering therapy granulocytopenia ( white blood cell &lt; 3,000/mm3 ) thrombocytopenia ( platelet &lt; 100,000/mm3 ) , infection hepatitis B C , HIV past present malignancy mental illness interfere patient ability comply protocol drug alcohol abuse within one year baseline comedication strong inhibitor CYP3A4 Pgp like voriconazole , ketoconazole , diltiazem , verapamil , erythromycin comedication strong CYP3A4 Pgp inductor like rifampicin know hypersensitivity macrolides Rapamune</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>ADPKD</keyword>
	<keyword>autosomal dominant polycystic kidney disease</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>volumetry</keyword>
</DOC>